These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35986903)

  • 21. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
    Ai J; Wang J; Liu D; Xiang H; Guo Y; Lv J; Zhang Q; Li J; Zhang X; Li Q; Liang J; Guo X; Feng Y; Liu L; Zhang X; Qin W; Wang X; Rao W; Zhang Q; Tian Q; Zhang Y; Xie F; Jiang S; Yan Y; Qiu Y; Wu H; Hou Z; Zhang N; Zhang A; Ji J; Yang J; Huang J; Zhao Z; Gu Y; Bian L; Zhang Z; Zou S; Ji H; Ge G; Du X; Hou A; Zhu Y; Cong Q; Xu J; Zu H; Wang Y; Yan Z; Yan X; BianBa Y; Ci Q; Zhang L; Yang S; Gao X; Zhong L; He S; Liu C; Huang Y; Liu Y; Xu D; Zhu Q; Xu X; Lv M; Zhang W; Qi X
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1516-1524.e2. PubMed ID: 34942370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis.
    Li J; Ayada I; Wang Y; den Hoed CM; Kamar N; Peppelenbosch MP; de Vries AC; Li P; Pan Q
    Transplantation; 2022 Oct; 106(10):2068-2075. PubMed ID: 35761439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
    Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
    Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis.
    Lee ARYB; Wong SY; Chai LYA; Lee SC; Lee MX; Muthiah MD; Tay SH; Teo CB; Tan BKJ; Chan YH; Sundar R; Soon YY
    BMJ; 2022 Mar; 376():e068632. PubMed ID: 35236664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.
    Herrera S; Colmenero J; Pascal M; Escobedo M; Castel MA; Sole-González E; Palou E; Egri N; Ruiz P; Mosquera M; Moreno A; Juan M; Vilella A; Soriano A; Farrero M; Bodro M
    Am J Transplant; 2021 Dec; 21(12):3971-3979. PubMed ID: 34291552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS‑CoV‑2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine.
    Raszeja-Wyszomirska J; Janik MK; Wójcicki M; Milkiewicz P
    Pol Arch Intern Med; 2022 Aug; 132(7-8):. PubMed ID: 35671236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
    Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
    J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
    Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
    Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.
    Verleye A; Wijtvliet V; Abrams S; Hellemans R; Bougrea R; Massart A; Pipeleers L; Wissing KM; Ariën KK; De Winter BY; Van Damme P; Abramowicz D; Ledeganck KJ
    Nephrol Dial Transplant; 2022 Jul; 37(8):1566-1575. PubMed ID: 35544087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter regarding "COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis".
    Mungmunpuntipantip R; Wiwanitkit V
    Clin Mol Hepatol; 2023 Jan; 29(1):168-0. PubMed ID: 36314041
    [No Abstract]   [Full Text] [Related]  

  • 34. Seroconversion following a booster dose of COVID-19 vaccine in liver transplant recipients: a systematic review and meta-analysis.
    Gkoufa A; Lekakis V; Papatheodoridis G; Cholongitas E
    Pol Arch Intern Med; 2023 Sep; 133(9):. PubMed ID: 36876925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matched Versus Mixed COVID-19 Vaccinations in Korean Solid Organ Transplant Recipients: An Observational Study.
    Kang JM; Lee J; Huh KH; Joo DJ; Lee JG; Kim HR; Kim HY; Lee M; Jung I; Kim MY; Kim S; Park Y; Kim MS
    Transplantation; 2022 Sep; 106(9):e392-e403. PubMed ID: 35749755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral and cellular immune responses to Pfizer-BioNTech BNT162b2 SARS-CoV-2 vaccine in adolescents with liver transplantation: Single center experience.
    Sánchez-Zapardiel E; Alós M; Nozal P; González-Muñoz M; Frauca-Remacha E; Gavilán LB; Quiles MJ; Hierro L; López-Granados E
    Front Immunol; 2022; 13():1049188. PubMed ID: 36505469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus disease 2019 and the liver.
    Esteban JP; Sobotka L; Rockey DC
    Curr Opin Gastroenterol; 2022 May; 38(3):191-199. PubMed ID: 35275902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
    Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
    Front Immunol; 2022; 13():906225. PubMed ID: 35720376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients.
    Toapanta-Yanchapaxi L; Chiquete E; Ávila-Rojo E; López-Yánez S; Luna Del Villar Velasco S; Rivera Monroy S; López Gómez T; Andrés Aguilar JB; Balcázar Antonio DF; Alcaraz-Fuerte C; García Baysa M; López Jiménez JL; Márquez-Guillén E; Vilatobá M; Cruz-Martínez R; Carpinteyro-Espin P; Chávez-Villa M; Romero Morelos RD; Torres-Del Real D; Uscanga-Domínguez LF; García-Alanis M; Tapia Sosa R; Servín-Rojas M; Valdez-Echeverria RD; García-Juárez I
    Vaccine; 2022 Sep; 40(38):5621-5630. PubMed ID: 36028456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.